Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Idiopathic interstitial pneumonias (IIPs) have a progressive and often fatal course, and their enigmatic etiology has complicated approaches to effective therapies. Idiopathic pulmonary fibrosis (IPF) is the most common of IIPs and shares with IIPs an increased incidence with age and unexplained scarring in the lung. Short telomeres limit tissue renewal capacity in the lung and germ-line mutations in telomerase components, hTERT and hTR , underlie inheritance in a subset of families with IPF. To examine the hypothesis that short telomeres contribute to disease risk in sporadic IIPs, we recruited patients who have no family history and examined telomere length in leukocytes and in alveolar cells. To screen for mutations, we sequenced hTERT and hTR. We also reviewed the cases for features of a telomere syndrome. IIP patients had shorter leukocyte telomeres than age-matched controls ( P < 0.0001). In a subset (10%), IIP patients had telomere lengths below the first percentile for their age. Similar to familial cases with mutations, IPF patients had short telomeres in alveolar epithelial cells ( P < 0.0001). Although telomerase mutations were rare, detected in 1 of 100 patients, we identified a cluster of individuals (3%) with IPF and cryptogenic liver cirrhosis, another feature of a telomere syndrome. Short telomeres are thus a signature in IIPs and likely play a role in their age-related onset. The clustering of cryptogenic liver cirrhosis with IPF suggests that the telomere shortening we identify has consequences and can contribute to what appears clinically as idiopathic progressive organ failure in the lung and the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, patients with IPF who have mutant telomerase genes are at an increased risk of developing bone marrow failure and liver disease54,71.”
From The telomere syndromes (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, telomere dysfunction in epithelial cells, or perhaps another cell type, might cause parenchymal organ remodelling, which manifests as fibrosis and/or emphysema46,54,99.”
From The telomere syndromes (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, circulating leukocytes and alveolar epithelial cells show shorter telomeres than age-matched individuals53.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“The frequency of these mutations is highest in individuals with the progressive disorder IPF, which accounts for 8–15% of familial and 1–3% of sporadic cases54,56,68,69.”
From The telomere syndromes (2012) · cites this paper as [54]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Lead SNPs at two loci (TERC and TERT) associate with several cancers and other diseases, including idiopathic pulmonary fibrosis.”
From Identification of seven loci affecting mean telomere length and their association with disease (2013) · cites this paper as [26]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 6×
“In IPF families with telomerase mutations, cases of aplastic anemia can be hidden and are uncovered after a thorough family history, suggesting that mutations in telomerase have heterogeneous manifestations in an individual patient and within families, and that a subset of families with IPF falls on the same spectrum…”
BackgroundInfluentialSelf-citationEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Greider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150
Cited by
Items 101–200 of 802
Noureddine, H., Gary-Bobo, G., Alifano, M., Marcos, E., Saker, M., Vienney, N., Amsellem, V., Maitre, B., Chaouat, A., Chouaid, C., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.241299 · Cited by 173
Telomerase gene mutations are associated with cirrhosis formation
Hartmann, D., Srivastava, U., Thaler, M., Kleinhans, K. N., N'Kontchou, G., Scheffold, A., Bauer, K., Kratzer, R. F., Kloos, N., Katz, S.-F., et al. (2011) · Hepatology · doi:10.1002/hep.24217 · Cited by 173
“Subsequent sequencing analysis (TERC and TERT exons 1 and 16 completely, TERT exons 2, 10, and 15 partially) was focused on mutated regions that were detected in the initially sequenced cohort as well as on telomerase mutation regions that were published in previous studies on other human diseases, such as DKC and idi…”
MethodMitochondria, telomeres and cell senescence: Implications for lung ageing and disease
Birch, J., Barnes, P. J., & Passos, J. F. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.005 · Cited by 170
“In patients with pulmonary fibrosis, telomere shortening is detectable in circulating leukocytes (Alder et al., 2008) and in alveolar type II cells in the lungs of patients with sporadic and familial pulmonary fibrosis (Alder et al., 2008).”
BackgroundInfluentialMolecular biomarkers in idiopathic pulmonary fibrosis
Ley, B., Brown, K. K., & Collard, H. R. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00014.2014 · Cited by 172
The molecular genetics of the telomere biology disorders
Bertuch, A. A. (2016) · RNA Biology · doi:10.1080/15476286.2015.1094596 · Cited by 169
“those with familial IPF or sporadic IPF with a known telomere associated gene mutation.(46,80) This may account for the”
BackgroundBarkauskas, C. E., & Noble, P. W. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00321.2013 · Cited by 167
Latella, G., Rogler, G., Bamias, G., Breynaert, C., Florholmen, J., Pellino, G., Reif, S., Speca, S., & Lawrance, I. C. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.03.008 · Cited by 164
Blue Journal Conference. Aging and Susceptibility to Lung Disease
Thannickal, V. J., Murthy, M., Balch, W. E., Chandel, N. S., Meiners, S., Eickelberg, O., Selman, M., Pardo, A., White, E. S., Levy, B. D., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1876pp · Cited by 166
“patients with shortened telomeres are at increased risk of developing pulmonary fibrosis (25, 26) and telomere shortening has been noted in patients with emphysema”
BackgroundSelf-citationHeterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
Kannengiesser, C., Borie, R., Ménard, C., Réocreux, M., Nitschké, P., Gazal, S., Mal, H., Taillé, C., Cadranel, J., Nunes, H., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00040115 · Cited by 162
Stenmark, K. R., Frid, M. G., Graham, B. B., & Tuder, R. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy004 · Cited by 162
Self-citationWang, R., Song, F., Li, S., Wu, B., Gu, Y., & Yuan, Y. (2019) · Drug Design, Development and Therapy · doi:10.2147/dddt.s194787 · Cited by 160
“All over the world, it is difficult to detect and effectively treat liver fibrosis.(25) Recent research studies have been focusing on the assessment of various noninvasive procedures to evaluate the liver fibrosis.”
BackgroundImmunosenescence: signaling pathways, diseases and therapeutic targets
Fu, Y., Wang, B., Alu, A., Hong, W., Hong, L., He, X., Shi, H., Cheng, P., & Yang, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02371-z · Cited by 187
“262,266 The complex interplay between immunosenescence and autoimmunity highlights the importance of further research and the development of novel therapeutic approaches to treat autoimmune diseases in the elderly population.”
Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis
Kropski, J. A., Lawson, W. E., Young, L. R., & Blackwell, T. S. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010736 · Cited by 158
Liver fat accumulation is associated with circulating PCSK9
Ruscica, M., Ferri, N., Macchi, C., Meroni, M., Lanti, C., Ricci, C., Maggioni, M., Fracanzani, A. L., Badiali, S., Fargion, S., et al. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1188328 · Cited by 152
Reflections on telomere dynamics and ageing-related diseases in humans
Aviv, A., & Shay, J. W. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0436 · Cited by 156
“dyskeratosis congenita [4] and idiopathic pulmonary fibrosis [5]—genetically inherited diseases marked by critically short TL.”
BackgroundA Novel Dyskerin (DKC1) Mutation Is Associated With Familial Interstitial Pneumonia
Kropski, J. A., Mitchell, D. B., Markin, C. R., Polosukhin, V. V., Choi, L., Johnson, J. E., Lawson, W. E., Phillips, J. A., Cogan, J. D., Blackwell, T. S., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-2224 · Cited by 155
Self-citationLong telomeres and cancer risk: the price of cellular immortality
McNally, E. J., Luncsford, P. J., & Armanios, M. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120851 · Cited by 167
“5, is associated with IPF risk (77, 86), consistent with the known link between short telomeres and IPF risk (41).”
BackgroundResultSelf-citationUnravelling the progressive pathophysiology of idiopathic pulmonary fibrosis
Günther, A., Korfei, M., Mahavadi, P., von der Beck, D., Ruppert, C., & Markart, P. (2012) · European Respiratory Review · doi:10.1183/09059180.00001012 · Cited by 149
Kuwano, K., Araya, J., Hara, H., Minagawa, S., Takasaka, N., Ito, S., Kobayashi, K., & Nakayama, K. (2016) · Respiratory Investigation · doi:10.1016/j.resinv.2016.03.010 · Cited by 153
“In sporadic IPF, telomere shortening is similar to mutation carriers of IPF in peripheral blood leukocytes and alveolar epithelial cells, compared with those of healthy controls [54,55].”
BackgroundBorie, R., Kannengiesser, C., Hirschi, S., Le Pavec, J., Mal, H., Bergot, E., Jouneau, S., Naccache, J.-M., Revy, P., Boutboul, D., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.11.010 · Cited by 143
It all comes together at the ends: Telomerase structure, function, and biogenesis
Podlevsky, J. D., & Chen, J. J.-L. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.11.002 · Cited by 144
Self-citationGenetics of leukocyte telomere length and its role in atherosclerosis
Aviv, A. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.05.001 · Cited by 143
Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study
Zhang, C., Doherty, J. A., Burgess, S., Hung, R. J., Lindström, S., Kraft, P., Gong, J., Amos, C. I., Sellers, T. A., Monteiro, A. N. A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv252 · Cited by 142
“However, correlations between TLmeasured in blood andTLmeasured in lung (63,64) and other tissues (65) have been reported (r = 0.”
BackgroundEpigenetics of idiopathic pulmonary fibrosis
Yang, I. V., & Schwartz, D. A. (2015) · Translational Research · doi:10.1016/j.trsl.2014.03.011 · Cited by 139
Povedano, J. M., Martinez, P., Serrano, R., Tejera, Á., Gómez-López, G., Bobadilla, M., Flores, J. M., Bosch, F., & Blasco, M. A. (2018) · eLife · doi:10.7554/elife.31299 · Cited by 139
Dyskeratosis congenita as a disorder of telomere maintenance
Nelson, N. D., & Bertuch, A. A. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.06.008 · Cited by 140
The impact of emphysema in pulmonary fibrosis
Cottin, V. (2013) · European Respiratory Review · doi:10.1183/09059180.00000813 · Cited by 137
Interstitial lung diseases in children
Clément, A., Nathan, N., Epaud, R., Fauroux, B., & Corvol, H. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-22 · Cited by 160
“The limited life span of cells may result from replicative senescence in response to various stresses including DNA damage, oxidants, and telomere erosion [52].”
BackgroundThe Chromatin Landscape of Cellular Senescence
Criscione, S. W., Teo, Y. V., & Neretti, N. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.09.005 · Cited by 137
“Further supporting their key role in aging is evidence that humans born with abnormally short telomeres due to inherited defects in telomere maintenance experience accelerated age-associated pathologies due to impaired tissue renewal capacity [14, 15].”
BackgroundDisayabutr, S., Kim, E. K., Cha, S.-I., Green, G., Naikawadi, R. P., Jones, K. D., Golden, J. A., Schroeder, A., Matthay, M. A., Kukreja, J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158367 · Cited by 136
“766 2.025 2.224 2.439 14.514 2.024 miR-197 miR-210 miR-886 miR-939 miR-1183 miR-1229 miR-1268 0.426 0.406 0.399 0.472 0.451 0.481 0.446 Higher in miR-449b miR-449c miR-551b 2.870 6.006 5.413 3.900 4.480 IPF = idiopathic pulmonary fibrosis; AECs = alveolar epithelial cells”
InfluentialStrong, M. A., Vidal-Cardenas, S. L., Karim, B., Yu, H., Guo, N., & Greider, C. W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05312-11 · Cited by 139
“Short telomeres are also associated with a broad spectrum of degenerative disorders that are linked to aging, including aplastic anemia, pulmonary fibrosis, liver disease, and others (1, 4, 5, 11, 41, 70, 78, 79).”
BackgroundFrom ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
Michalski, J. E., Kurche, J. S., & Schwartz, D. A. (2021) · Translational research · doi:10.1016/j.trsl.2021.09.001 · Cited by 145
“Additionally, genetic variants in at least 5 telomere related genes which functionally shorten telomere length have been associated with increased risk of IPF.(96-103) Even without these telomere-shortening mutations, IPF patients have telomeres that are shorter than agematched controls.”
BackgroundNewton, C. A., Kozlitina, J., Lines, J. R., Kaza, V., Torres, F., & Garcia, C. K. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.02.005 · Cited by 132
Biomarkers in idiopathic pulmonary fibrosis
Drakopanagiotakis, F., Wujak, L., Wygrecka, M., & Markart, P. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.023 · Cited by 132
Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis
Wiley, C. D., Brumwell, A. N., Davis, S. S., Jackson, J. R., Valdovinos, A., Calhoun, C., Alimirah, F., Castellanos, C. A., Ruan, R., Wei, Y., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130056 · Cited by 132
“reported in AECIIs and fibroblasts in IPF lungs (8, 9).”
BackgroundCancer spectrum and outcomes in the Mendelian short telomere syndromes
Schratz, K. E., Haley, L., Danoff, S. K., Blackford, A. L., DeZern, A. E., Gocke, C. D., Duffield, A. S., & Armanios, M. (2020) · Blood · doi:10.1182/blood.2019003264 · Cited by 132
Self-citationIdiopathic Pulmonary Fibrosis: Evolving Concepts
Ryu, J. H., Moua, T., Daniels, C. E., Hartman, T. E., Yi, E. S., Utz, J. P., & LIMPER, A. H. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.03.016 · Cited by 143
“Given that IPF generally affects middle-aged to older persons, age-related biological changes including telomeric function probably play an important role as well.(21) These processes may lead to premature cellular senescence in alveolar cells and exhaustion of precursor cells needed in alveolar regeneration, thus res…”
BackgroundGenetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
Kaur, A., Mathai, S. K., & Schwartz, D. A. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00154 · Cited by 129
“Short telomeres (<10th percentile adjusted for age) have been identified in a considerable portion of IPF patients, regardless of genetic mutations (33, 34).”
BackgroundEuropean Respiratory Society statement on familial pulmonary fibrosis
Borie, R., Kannengiesser, C., Antoniou, K. M., Bonella, F., Crestani, B., Fabre, A., Froidure, A., Galvin, L., Griese, M., Grutters, J. C., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01383-2022 · Cited by 147
“The hepatic phenotype associated with TRG mutations is heterogeneous, ranging from asymptomatic increased liver enzymes reported in 5 – 27% to cryptogenic or secondary cirrhosis [8, 10, 34].”
BackgroundHepatopulmonary Syndrome Is a Frequent Cause of Dyspnea in the Short Telomere Disorders
Gorgy, A. I., Jonassaint, N. L., Stanley, S. E., Koteish, A. A., Dezern, A. E., Walter, J. E., Sopha, S. C., Hamilton, J. P., Hoover-Fong, J. E., Chen, A. R., et al. (2015) · CHEST Journal · doi:10.1378/chest.15-0825 · Cited by 133
Self-citationIdiopathic Pulmonary Fibrosis: Update on Genetic Discoveries
Garcia, C. K. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201008-056ms · Cited by 126
“The central role of short telomere lengths in IPF has been demonstrated in two independent studies (27, 32).”
BackgroundTelomere-mediated lung disease
Alder, J. K., & Armanios, M. (2022) · Physiological Reviews · doi:10.1152/physrev.00046.2021 · Cited by 130
Self-citationThe Role of Telomeres in Human Disease
Armanios, M. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-010422-091101 · Cited by 126
“A third piece of evidence derives from the fact that the risk of lung disease is shared between individuals with inherited mutations in telomerase and those with short telomeres in the population (3).”
BackgroundSelf-citationProgress in Understanding and Treating Idiopathic Pulmonary Fibrosis
Kropski, J. A., & Blackwell, T. S. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-041317-102715 · Cited by 137
Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches
Glass, D. S., Grossfeld, D. J., Renna, H. A., Agarwala, P., Spiegler, P. A., Kasselman, L. J., Glass, A. D., DeLeon, J. R., & Reiss, A. B. (2020) · Respiratory Investigation · doi:10.1016/j.resinv.2020.04.002 · Cited by 138
Short telomere length in IPF lung associates with fibrotic lesions and predicts survival
Snetselaar, R., van Batenburg, A. A., van Oosterhout, M. F. M., Kazemier, K. M., Roothaan, S. M., Peeters, T., van der Vis, J. J., Goldschmeding, R., Grutters, J. C., & van Moorsel, C. H. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189467 · Cited by 131
Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis
Selman, M., López-Otín, C., & Pardo, A. (2016) · European Respiratory Journal · doi:10.1183/13993003.00398-2016 · Cited by 122
The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary Fibrosis
Kim, S.-J., Cheresh, P., Jablonski, R. P., Williams, D. B., & Kamp, D. W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921486 · Cited by 138
“One study showed that AT2 cells from 97% of 62 IPF patients (both sporadic and familial) had shortened telomeres [73].”
BackgroundIdiopathic pulmonary fibrosis: An update
Spagnolo, P., Sverzellati, N., Rossi, G., Cavazza, A., Tzouvelekis, A., Crestani, B., & Vancheri, C. (2015) · Annals of Medicine · doi:10.3109/07853890.2014.982165 · Cited by 120
Extracellular Vesicles from Fibroblasts Induce Epithelial-Cell Senescence in Pulmonary Fibrosis
Kadota, T., Yoshioka, Y., Fujita, Y., Araya, J., Minagawa, S., Hara, H., Miyamoto, A., Suzuki, S., Fujimori, S., Kohno, T., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0002oc · Cited by 134
Alder, J. K., Cogan, J. D., Brown, A. F., Anderson, C. J., Lawson, W. E., Lansdorp, P. M., Phillips, J. A., Loyd, J. E., Chen, J. J.-L., & Armanios, M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001352 · Cited by 119
“A subset of pulmonary fibrosis patients and families with short telomeres suffer complications from aplastic anemia and cryptogenic liver cirrhosis [12,13,20,21].”
BackgroundMethodInfluentialSelf-citationRecommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders
Walsh, M. F., Chang, V. Y., Kohlmann, W. K., Scott, H. S., Cunniff, C. M., Bourdeaut, F., Molenaar, J. J., Porter, C. C., Sandlund, J. T., Plon, S. E., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0465 · Cited by 127
The Adventitia: Essential Role in Pulmonary Vascular Remodeling
Stenmark, K. R., Nozik‐Grayck, E., Gerasimovskaya, E. V., Anwar, A., Li, M., Riddle, S. R., & Frid, M. G. (2010) · Comprehensive physiology · doi:10.1002/cphy.c090017 · Cited by 140
Tissue remodelling in pulmonary fibrosis
Knudsen, L., Ruppert, C., & Ochs, M. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2543-2 · Cited by 129
“Moreover, shortened telomeres have been observed directly in the AE2 of familial IPF patients and have even been commonly detected in AE2 of sporadic IPF cases, in the absence of any gene mutations in the telomerase complex (Alder et al. 2008).”
BackgroundPopescu, I., Mannem, H. C., Winters, S. A., Hoji, A., Silveira, F. P., McNally, E. J., Pipeling, M. R., Lendermon, E. A., Morrell, M. R., Pilewski, J. M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201805-0825oc · Cited by 119
Self-citationJohannson, K. A., Balmes, J. R., & Collard, H. R. (2015) · CHEST Journal · doi:10.1378/chest.14-1299 · Cited by 136
Kumar, A., Cherian, S. V., Vassallo, R., Yi, E. S., & Ryu, J. H. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.11.023 · Cited by 118
Cell senescence and fibrotic lung diseases
Liu, R.-M., & Liu, G. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110836 · Cited by 113
Viral infection and aging as cofactors for the development of pulmonary fibrosis
Naik, P. K., & Moore, B. B. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.10.73 · Cited by 113
Chang, W., Wei, K., Jacobs, S. S., Upadhyay, D., Weill, D., & Rosen, G. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025684 · Cited by 113
Idiopathic Pulmonary Fibrosis: From Epithelial Injury to Biomarkers - Insights from the Bench Side
Kolb, Borensztajn, K., Crestani, B., & Kolb, M. (2013) · Respiration · doi:10.1159/000357598 · Cited by 113
Veith, C., Boots, A. W., Idris, M., van Schooten, F., & van der Vliet, A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7742 · Cited by 119
“Indeed, common hallmarks of aging, including genomic instability, telomere shortening, epigenetic alterations, loss of proteostasis, dysregulated nutrient sensing, mitochondrial dysfunction, cellular senescence/apoptosis, stem cell exhaustion, and distorted intercellular communication (132), are also seen in IPF and f…”
BackgroundTelomere Length in Interstitial Lung Diseases
Snetselaar, R., van Moorsel, C. H. M., Kazemier, K. M., van der Vis, J. J., Zanen, P., van Oosterhout, M. F. M., & Grutters, J. C. (2015) · CHEST Journal · doi:10.1378/chest.14-3078 · Cited by 122
Smoking and Idiopathic Pulmonary Fibrosis
Oh, C. K., Murray, L. A., & Molfino, N. A. (2012) · Pulmonary Medicine · doi:10.1155/2012/808260 · Cited by 132
“Heterozygous loss-of-function mutations in TERT have been found in up to 15% of kindreds with familial pulmonary fibrosis [108, 109] and in 1% to 3% of sporadic cases [110, 111].”
BackgroundBiomarkers in idiopathic pulmonary fibrosis
Zhang, Y., & Kaminski, N. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328356d03c · Cited by 109
“[20] demonstrated that IIP patients had shorter telomeres when compared to age-matched controls in leukocytes and alveolar epithelial cells (P<0.”
Resultde Leon, A. D., Cronkhite, J. T., Yılmaz, C., Brewington, C. C., Wang, R. C., Xing, C., Hsia, C. C. W., & Garcia, C. K. (2011) · CHEST Journal · doi:10.1378/chest.10-2865 · Cited by 116
GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosis
Zhang, Y., Jiang, M., Nouraie, M., Roth, M. G., Tabib, T., Winters, S., Chen, X., Sembrat, J., Chu, Y., Cardenes, N., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00062.2019 · Cited by 107
“present in the majority of all IPF patients (4), supporting a”
BackgroundSelf-citationFBW7 Mediates Senescence and Pulmonary Fibrosis through Telomere Uncapping
Wang, L., Chen, R., Li, G., Wang, Z., Liu, J., Liang, Y., & Liu, J.-P. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.004 · Cited by 109
Lansdorp, P. M. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.172 · Cited by 108
Self-citationMechanistic links between aging and lung fibrosis
Thannickal, V. J. (2013) · Biogerontology · doi:10.1007/s10522-013-9451-6 · Cited by 107
“Shortening of telomeres, in the absence of telomerase mutations, is observed in sporadic cases (Alder et al. 2008; Cronkhite et al. 2008), suggesting that this may be a common pathophysiological mechanism resulting from a combination of genetic, environmental, and age-related causes (Thannickal and Loyd 2008).”
Fibroblast Senescence in Idiopathic Pulmonary Fibrosis
Lin, Y., & Xu, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.593283 · Cited by 115
Biology of Radiation-Induced Lung Injury
Roy, S., Salerno, K. E., & Citrin, D. E. (2021) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2020.11.006 · Cited by 112
Disease progression and clinical outcomes in telomere biology disorders
Niewisch, M. R., Giri, N., McReynolds, L. J., Alsaggaf, R., Bhala, S., Alter, B. P., & Savage, S. A. (2022) · Blood · doi:10.1182/blood.2021013523 · Cited by 103
Short Telomeres Compromise β-Cell Signaling and Survival
Guo, N., Parry, E. M., Li, L.-S., Kembou, F., Lauder, N., Hussain, M. A., Berggren, P.-O., & Armanios, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017858 · Cited by 100
“Insulin data were normalized to DNA content using PicoGreen (Invitrogen).”
MethodInfluentialSelf-citationMUC5B and Idiopathic Pulmonary Fibrosis
Yang, I. V., Fingerlin, T. E., Evans, C. M., Schwarz, M. I., & Schwartz, D. A. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201503-110aw · Cited by 100
Novel insights from a multiomics dissection of the Hayflick limit
Chan, M., Yuan, H., Soifer, I., Maile, T. M., Wang, R. Y., Ireland, A., O'Brien, J. J., Goudeau, J., Chan, L. J., Vijay, T., et al. (2022) · eLife · doi:10.7554/elife.70283 · Cited by 99
“( Tsakiri et al., 2007 ; Armanios et al., 2007 ; Cronkhite et al., 2008 ; Alder et al., 2008 ; Stuart et al., 2015 ; Raghu et al., 2006 ; Duckworth et al., 2021 ; Stuart et al., 2014 ; Dai et al., 2015 ).”
Fernandez, B. A., Fox, G. A., Bhatia, R., Sala, E., Noble, B., Denic, N., Fernandez, D., Duguid, N., Dohey, A., Kamel, F., et al. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-64 · Cited by 108
“[18] screened 100 sporadic PF patients and found that 10% had telomere lengths < 1 percentile for age, and Cronkhite et al.”
BackgroundLiang, J., Huang, G., Liu, X., Taghavifar, F., Liu, N., Wang, Y., Deng, N., Yao, C., Xie, T., Kulur, V., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157338 · Cited by 106
“Phenotypes of cellular aging, including epithelial cell apoptosis (19, 20), autophagy (21), senescence (22), telomere shortening (23, 24), mitochondria dysfunction (25, 26), and oxidative stress (27), are all observed in IPF lungs.”
Cárdenes, N., Álvarez, D., Sellarés, J., Peng, Y., Corey, C., Wecht, S., Nouraie, S. M., Shanker, S., Sembrat, J., Bueno, M., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0970-6 · Cited by 97
Shivshankar, P., Brampton, C., Miyasato, S., Kasper, M., Thannickal, V. J., & Le Saux, C. J. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0349oc · Cited by 95
“The two common factors that link senescence with lung injury and fibrosis are telomere shortening and reactive oxygen species–mediated stress (40, 41).”
BackgroundAssociation between telomere length and survival in patients with idiopathic pulmonary fibrosis
Dai, J., Cai, H., Li, H., Zhuang, Y., Min, H., Wen, Y., Yang, J., Gao, Q., Shi, Y., & Yi, L. (2015) · Respirology · doi:10.1111/resp.12566 · Cited by 94
Interstitial Lung Diseases in Developing Countries
Rivera‐Ortega, P., & Molina‐Molina, M. (2019) · Annals of Global Health · doi:10.5334/aogh.2414 · Cited by 104
Modern Concepts on the Role of Inflammation in Pulmonary Fibrosis
Homer, R. J., Elias, J. A., Lee, C. G., & Herzog, E. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0296-ra.1 · Cited by 92
Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis
Kropski, J. A., Young, L. R., Cogan, J. D., Mitchell, D. B., LANCASTER, L. H., Worrell, J. A., Markin, C. R., Liu, N., Mason, W. R., Fingerlin, T. E., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1820pp · Cited by 103
“It is recognized that approximately one-third of patients with IPF have short telomeres (less than the 10th percentile, adjusted for age) in peripheral blood (39, 40), and telomere length is shorter in patients with IPF compared with that in patients with other interstitial lung diseases (41).”
ResultSelf-citationEpigenetic Mechanisms Impacting Aging: A Focus on Histone Levels and Telomeres
Song, S., & Johnson, F. B. (2018) · Genes · doi:10.3390/genes9040201 · Cited by 101
The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis
Saito, A., Horie, M., Micke, P., & Nagase, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113611 · Cited by 90
“Even in the absence of mutations in the telomere-related genes, shortening of telomeres in alveolar epithelial cells is commonly found in IPF patients [34].”
BackgroundChiang, G. C., & Parimon, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032405 · Cited by 101
“The telomere shortening can be detected in lymphocytes, granulocytes, and alveolar epithelial cells [22].”
BackgroundInfluence of age on wound healing and fibrosis
Kapetanaki, M. G., Mora, A. L., & Rojas, M. (2013) · The Journal of Pathology · doi:10.1002/path.4122 · Cited by 90
Autonomic and adrenocortical reactivity and buccal cell telomere length in kindergarten children
Kroenke, C. H., Epel, E., Adler, N., Bush, N. R., Obradović, J., Lin, J., Blackburn, E., Stamperdahl, J. L., & Boyce, W. T. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318229acfc · Cited by 89
“TL in other types of epithelial cells has also predicted age-related disease (16).”
BackgroundTelomere length: lights and shadows on their role in human reproduction
Rocca, M. S., Foresta, C., & Ferlin, A. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy208 · Cited by 104
Targeting NOX enzymes in pulmonary fibrosis
Hecker, L., Cheng, J., & Thannickal, V. J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1012-7 · Cited by 89
“More recent concepts have focused on the possibility that IPF may represent a degenerative disease of aging; studies of familial and sporadic cases of IPF have been associated with telomere shortening [3, 13, 55], supporting the concept that IPF may represent an age-related degenerative disease process [53].”
BackgroundShort telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
Gramatges, M. M., & Bertuch, A. A. (2013) · Translational Research · doi:10.1016/j.trsl.2013.05.003 · Cited by 88
O'Dwyer, D. N., Ashley, S. L., & Moore, B. B. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00221.2016 · Cited by 88
Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis
Kasper, M., & Barth, K. (2017) · Bioscience Reports · doi:10.1042/bsr20171301 · Cited by 88
Lucid, C., Savani, B. N., Engelhardt, B. G., Shah, P. D., Clifton, C., Greenhut, S. L., Vaughan, L. A., Kassim, A. A., Schuening, F., & Jagasia, M. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.152 · Cited by 87
Cellular Senescence: The Trojan Horse in Chronic Lung Diseases
Hamsanathan, S., Alder, J. K., Sellares, J., Rojas, M., Gurkar, A. U., & Mora, A. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0410tr · Cited by 86
“Mutations in at least seven genes related to telomere maintenance have been found in families with inherited IPF (90–96), and short telomeres are found in the majority of patients (97, 98).”
BackgroundSelf-citationTelomeres in Interstitial Lung Disease: The Short and the Long of It
Courtwright, A., & El‐Chemaly, S. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201808-508cme · Cited by 88
Tobacco Smoke–Induced Lung Fibrosis and Emphysema
Morse, D., & Rosas, I. O. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170411 · Cited by 84
S2K-Leitlinie zur Diagnostik und Therapie der idiopathischen Lungenfibrose
Behr, J., Günther, A., Ammenwerth, W., Bittmann, I., Bonnet, R. B., Buhl, R., Eickelberg, O., Ewert, R., Gläser, S., Gottlieb, J., et al. (2013) · Pneumologie · doi:10.1055/s-0032-1326009 · Cited by 110
Katzenstein, A.-L. A. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.154 · Cited by 88
Metadata
- Authors
- Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., Phillips, J. A., Lansdorp, P. M., Loyd, J. E., & Armanios, M. Y.
- Affiliations
- Johns Hopkins University (US)
- Arizona State University (US)
- Vanderbilt University (US)
- BC Cancer Agency (CA)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-02
- Volume
- 105
- Issue
- 35
- Pages
- 13051-13056
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2529100
- OpenAlex
- W2147238277
- Cited by
- 805
- References
- 35
- Citations by year
- 2026: 32 · 2025: 40 · 2024: 38 · 2023: 48 · 2022: 45 · 2021: 61 · 2020: 53 · 2019: 60 · 2018: 54 · 2017: 40 · 2016: 36 · 2015: 56 · 2014: 45 · 2013: 45 · 2012: 40
- FWCI
- 33.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Doris Duke Charitable Foundation
- Johns Hopkins University
- National Institutes of Health
- U.S. Public Health Service (T32 60441, K08 118416)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, idiopathic interstitial pneumonia, telomere length, short telomeres, telomerase mutations, hTERT, hTR, leukocytes, alveolar epithelial cells, cryptogenic cirrhosis, disease risk
- MeSH terms
- Epithelium, Family, Fibrosis, Heterozygote, Humans, Leukocytes, Mononuclear, Pulmonary Alveoli, Pulmonary Fibrosis, Risk Factors, RNA, Tomography, X-Ray Computed, Biomarkers, Case-Control Studies, Telomere, In Situ Hybridization, Fluorescence, Germ-Line Mutation, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.